Not Yet RecruitingPhase 4ACTRN12607000613404

An Assessment of the Effects of a Nutritional Supplement Program on Healthy Aging

In patients with osteoarthritis of the knee does Ambrotose powder, Ambrotose AO, Phytomatrix and Plus 1, increase the quality of life and fatigue level?


Sponsor

Mannatech Australia Pty Ltd

Enrollment

20 participants

Start Date

Feb 20, 2008

Study Type

Interventional

Conditions

Summary

The purpose of the study is to determine the efficacy and safety of a Mannatech product in improving quality of life and reducing fatigue in participants with diagnosed osteoarthritis of the knee. Participants will take 4 Mannatech preperations twice a day with food for 8 weeks, they will attend a clinic at baseline, week 4 and week 8. At these times they will complete the study questionnaires. Blood wil be taken at baseline and week 8 to determine safety parameters.


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 85 Yearss

Inclusion Criteria5

  • Females and males, aged between 18 and 85 years
  • X-ray and clinical evidence of osteoarthritis of the knees
  • In good general health
  • Adequate venous access
  • Female participants of childbearing age who agree to continue using birth control measures for the duration of the study

Exclusion Criteria18

  • A history of trauma associated with the affected joint
  • Rheumatoid or other inflammatory joint conditions
  • Gout
  • Individuals with thyroid disorder
  • Individuals with diabetes
  • Individuals taking antidepressants
  • Individuals taking Warfarin of other anti-coagulant medication
  • Individuals who are lactose intolerant
  • Participants with a VAS score above 7 at baseline.
  • Participants who have just commenced on a treatment regimen for arthritis
  • Use of corticosteroids (intra-articular or systematic) within 4 weeks prior to baseline and throughout the study
  • Liver function tests greater than 3 times the upper limit of normal at baseline
  • History of alcohol or substance abuse
  • History of allergy to iodine or shell fish
  • Female participants who are lactating, pregnant or planning to become pregnant
  • Participants who have participated in another clinical trial in the last 30 days
  • Participants unwilling to comply with the study protocol
  • Any other condition, which in the opinion of the investigators could compromise the study

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Ambrotose powder 1 teaspoon twice a day with food for 8 weeks Ambrotose AO, 2 capsules twice a day with food for 8 weeks Phytomatrix 1 capsule twice a day with food for 8 weeks Plus 1 capsule twice

Ambrotose powder 1 teaspoon twice a day with food for 8 weeks Ambrotose AO, 2 capsules twice a day with food for 8 weeks Phytomatrix 1 capsule twice a day with food for 8 weeks Plus 1 capsule twice a day with food for 8 weeks


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12607000613404